These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22908995)

  • 1. The effect of selected pre-analytical phase variables on plasma thromboxane A₂ measurements in humans.
    Sadilkova L; Paluch Z; Mottlova J; Bednar F; Alusik S
    Int J Lab Hematol; 2013 Feb; 35(1):92-100. PubMed ID: 22908995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The purification step is not crucial in EIA measurements of thromboxane B2 and 11-dehydrothromboxane B2 in human plasma.
    Sadilkova L; Paluch Z; Mottlova J; Bednar F; Alusik S
    Clin Lab; 2012; 58(1-2):177-83. PubMed ID: 22372363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
    Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement.
    Petrucci G; Rizzi A; Cavalca V; Habib A; Pitocco D; Veglia F; Ranalli P; Zaccardi F; Pagliaccia F; Tremoli E; Patrono C; Rocca B
    Thromb Haemost; 2016 Oct; 116(5):891-896. PubMed ID: 27440714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of thromboxane in blood samples.
    Helgadóttir H; Ólafsson Í; Andersen K; Gizurarson S
    Vasc Health Risk Manag; 2019; 15():143-147. PubMed ID: 31239692
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
    Int J Cardiol; 2011 Jul; 150(1):39-44. PubMed ID: 20207433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays.
    Huszár E; Szabó Z; Jakab A; Barta I; Herjavecz I; Horváth I
    Inflamm Res; 2005 Aug; 54(8):350-5. PubMed ID: 16158336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of oxidative-stress-induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets.
    Li S; Li X; Li J; Deng X; Li Y
    Steroids; 2007 Nov; 72(13):875-80. PubMed ID: 17825336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.
    Dragani A; Pascale S; Recchiuti A; Mattoscio D; Lattanzio S; Petrucci G; Mucci L; Ferrante E; Habib A; Ranelletti FO; Ciabattoni G; Davì G; Patrono C; Rocca B
    Blood; 2010 Feb; 115(5):1054-61. PubMed ID: 19887674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane-B(2) levels in serum of rabbits receiving a single intravenous dose of aqueous extract of garlic and onion.
    Thomson M; Mustafa T; Ali M
    Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):217-21. PubMed ID: 11049697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin resistance.
    Tantry US; Mahla E; Gurbel PA
    Prog Cardiovasc Dis; 2009; 52(2):141-52. PubMed ID: 19732606
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events.
    Richard S; Toussaint-Hacquard M; Fay R; Lacour JC; Ducrocq X; Lecompte T
    Cerebrovasc Dis; 2012; 33(6):574-8. PubMed ID: 22710855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin 'resistance': role of pre-existent platelet reactivity and correlation between tests.
    Frelinger AL; Li Y; Linden MD; Tarnow I; Barnard MR; Fox ML; Michelson AD
    J Thromb Haemost; 2008 Dec; 6(12):2035-44. PubMed ID: 18983514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.